Additionally, we demonstrated that niclosamide inhibits cisplatin-induced oral cancer stem cell enrichment and enhances sensitivity of the ALDH+ OSCC cells to cisplatin treatment. The gene discussed is LDHA; the disease is lip and oral cavity carcinoma.